MGMT and central nervous system cancer: Our findings are consistent with the demonstrations that VPA is effective on GBM cell lines through inhibition of histone deacetylases (HDACs) [38] and that combined VPA + TMZ treatment is effective on glioma cell lines, mainly on TMZ-resistant ones, where VPA down-regulates at protein level the expression of the MGMT [39, 40].